In continuation to communication dated November 17, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Gufic Biosciences has informed that written transcript of the said call held on November 17, 2023 at 4:30 pm, has been uploaded on the Company’s website (link attached).
The above information is a part of company’s filings submitted to BSE.